Replies to post #324615 on Anavex Life Sciences Corp (AVXL)

[bas2020]

When a passionate organization comes to the FDA with trial efficacy & safety results, I would believe it would get more attention from the FDA... in addition to discussions and review that the FDA has already had with the company.

AVATAR results will be the final proof that gets it done for Rett approval... first with TGA, then FDA.

[Bourbon_on_my_cornflakes]

INCORRECT LOGIC: Putting aside your financial interest in Anavex, what makes Rett syndrome more important than, say, the diseases that other rare disease biotechs are focusing on? Allievex, NeuroVive, there are dozens of companies just like Anavex.

Sure there are dozens of companies working on rare diseases, but they don't all show up on the same day with data from a completed study with super results like AVXL has.

This is a rare and horrific disease that affects girls. Can't think of a better chance to get a fast hearing, especially since there are zero treatments and super safety record. And the Rett organization will help make it happen.

[Investor2014]

Think Sarepta, Eteplersin, Woodcock and some very vocal advocacy mum's as an example.

I didn't expect FDA to approve Eterlersin, but I held on to my position in Serapta because of the advocacy and how the families showed up at the FDA with their boys.